コンテンツへスキップ
Merck
  • Ni(2+)-sensitive T-type Ca(2+) channel currents are regulated in parallel with synaptic and visual response plasticity in visual cortex.

Ni(2+)-sensitive T-type Ca(2+) channel currents are regulated in parallel with synaptic and visual response plasticity in visual cortex.

Neuroscience research (2014-07-16)
Shoko Horibe, Etsuko Tarusawa, Yukio Komatsu, Yumiko Yoshimura
要旨

Visual cortical neurons undergo depression and potentiation of their visual responses to stimulation of the deprived and non-deprived eyes, respectively, after monocular deprivation. This modification occurs predominantly during an early postnatal period in normal development, and this critical period is postponed until adulthood in animals reared in darkness from birth. We have proposed that Ni(2+)-sensitive T-type Ca(2+) channel-dependent long-term potentiation (T-LTP) mediates the potentiation of non-deprived eye responses. In this study, to investigate the development of Ni(2+)-sensitive T-type Ca(2+) channels, presumed CaV3.2 channels, we performed whole-cell recordings from layer 2/3 pyramidal neurons in rat visual cortical slices. T-type Ca(2+) channel currents were activated by voltage steps from -100mV to -40mV under a pharmacological blockade of Na(+) and K(+) channels. We estimated presumed CaV3.2 currents from the currents obtained after subtraction of the currents in the presence of Ni(2+) (50μM) from those in control solution. The estimated currents were very small before eye opening, peaked during the critical period and then returned to a small value by adulthood. Dark rearing prevented the developmental decline in these currents until adulthood. These results suggest that the regulation of CaV3.2 currents underlies the developmental changes in T-LTP and ocular dominance plasticity.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
リドカイン, powder
Supelco
リドカイン, Pharmaceutical Secondary Standard; Certified Reference Material
USP
リドカイン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
リドカイン, analytical standard
Sigma-Aldrich
1,2-ビス(2-アミノフェノキシ)エタン-N,N,N′,N′-四酢酸, 98%
Sigma-Aldrich
DNQX, ≥98% (TLC)
Sigma-Aldrich
ニモジピン
Sigma-Aldrich
1,2-ビス(2-アミノフェノキシ)エタン-N,N,N′,N′-四酢酸, ≥96.0% (HPLC)
リドカイン, European Pharmacopoeia (EP) Reference Standard
Supelco
ニモジピン, Pharmaceutical Secondary Standard; Certified Reference Material
ニモジピン, European Pharmacopoeia (EP) Reference Standard